Cadex Genomics
@CadexGenomics
Followers
525
Following
236
Media
8
Statuses
51
Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into therapy response
St. Louis, Missouri, USA
Joined June 2018
At Cadex Genomics, we are interrogating a late-stage cancer patient's blood to determine if a tumor is growing early in a line of therapy and identify non-effective therapy in 12-21 days after starting a cycle of therapy versus waiting 8-12 weeks.
issuu.com
The central philosophy anchoring the AngelMD community is that we are all smarter and more effective working together. So it's befitting that the Premier Issue of MD Next centers on the theme that Inn
0
0
0
We're excited to have a new channel with which to showcase the entrepreneurs, physicians, dentists, investors & Industry stakeholders advancing healthcare innovation day in and day out.
Premier Issue is live: https://t.co/KRPIumCSiq
#startups #healthcare #therapeutics @medtech #diagnostics #digitalhealth #doctors #physicians #dentists @angelMD_Inc
0
3
3
Please join Cadex Genomics and AngelMD Capital at a webinar on Wednesday, August 17th to learn more about real-time therapy monitoring for cancer patients. Save your seat: https://t.co/qYps3eI3M4
0
0
1
Bill & the Cadex Genomics team are tackling an incredibly important part of the fight against Stage IV cancers.
New Episode: @CadexGenomics is taking the fight to Stage IV #cancer
https://t.co/SRdXOA0Vnn
#genomics #diagnostic
0
1
1
New Episode: @CadexGenomics is taking the fight to Stage IV #cancer
https://t.co/SRdXOA0Vnn
#genomics #diagnostic
0
2
5
#PitchClub starts at 6PM MT. Hear from @CadexGenomics & @scriptchain1. #startups #physicians #familyoffice #venturecapital #free
airmeet.com
Checkout this event on Airmeet
0
2
5
Today's #PitchClub revolves around #innovation in #Biotech, #Lab and #Precision medicine. Join us at 6PM MT as we have a discussion with our member startups, #healthcare experts, and innovators. To sign up, click here: https://t.co/dGVBjvpWFA
0
5
8
One of our guest speakers on our next #PitchClub is Bill Haack, CEO of Cadex Genomics. Join us with him on April 12 as we discuss more on #Innovation in #Biotech, #Lab and #Precision medicine. Register via this link: https://t.co/dGVBjvpWFA
#AngelMD
0
1
4
Our next #PitchClub revolves around #innovation in #Biotech, #Lab and #Precision medicine. Join us on April 12 as we have a discussion with our member startups, #healthcare experts, and innovators. To sign up, click here: https://t.co/dGVBjvI5TI
#AngelMD
0
2
4
Congratulations to the team @AxoSim.
We are excited to announce that we have received the first investment from the new @Benson_CP Fund!
0
0
3
Cadex Genomics founders Bill Haack and Greg Schafer talk about real-time cancer therapy monitoring on the MedTech Trends podcast. https://t.co/80VrdfoxVj
0
0
3
C&M intellectual property lawyers wrote about the recent Illumina v. Ariosa Diagnostics case in @IAM_Magazine, unpacking the news for diagnostics innovators. Read more:
cvsoci.al
C&M intellectual property lawyers wrote about the recent Illumina v. Ariosa Diagnostics case in Intellectual Asset Magazine, unpacking the news for diagnostics innovators. Read more:
0
1
3
Genetic testing for cancer, therapy monitoring, and recurrence - a +$50B addressable market. https://t.co/8hsvQvqY27
investors.com
Genetics stocks like Guardant Health and Exact Sciences are launching new genetic tests for cancer that help find cancer earlier and tailor treatments.
0
0
1
Happy to have contributed data to this important whitepaper.
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper | Nature Reviews Clinical Oncology. Notes the opportunities and gaps in knowledge. @VanMorrisMD and Arvind Dasari @MDAndersonNews
0
0
0
"...Diagnostics have been really taken for granted Its been viewed as a commodity for the industry, an afterthought. It isn’t valued properly in the whole healthcare continuum. It isn’t paid for properly. I think that’s changing now..." https://t.co/yCfORZnday
medcitynews.com
Steve Kafka, who joined Section 32 as a managing partner last fall, shared more about how the fund approaches investing across technology and healthcare. The company is currently raising $350 million...
0
0
0
The Daily Journal Names C&M Partner Kevin Kroeker “Top Healthcare Lawyer”
cvsoci.al
The Daily Journal named Kevin B. Kroeker to its “Top Healthcare Lawyers 2020” list for being one of California’s leading lawyers in the area of healthcare litigation, transactions, and counseling....
0
1
1
New blog post: Molecular Diagnostics: A Broken Business Model or Flawed Execution? https://t.co/9gTvoP8lIP
#cancer #cancertherapymonitoring #diagnostics
link.medium.com
Every idea needs a Medium
0
1
11
Flurry of Regulatory Activity Driven by COVID-19 Anxiety Impacts Health Plan Requirements and Permissible Actions - C&M #HealthLaw
cvsoci.al
The past week has seen daily action at the state and federal level that seeks to ensure that health plans and insurers are providing unrestricted access... Click to access this Health Law blog post...
0
2
2
#ICYMI: Gayle Benson, a favorite Saint, will invest $50 million in Gulf South startups with a new venture fund. A touchdown for economic growth and small business owners in our region. https://t.co/lFAOCMmCBo
0
4
16